![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | A61P 35/00 | |
A61K 39/00 |
(11) | Number of the document | 1677875 |
(13) | Kind of document | T |
(96) | European patent application number | 04769011.0 |
Date of filing the European patent application | 2004-10-22 | |
(97) | Date of publication of the European application | 2006-07-12 |
(45) | Date of publication and mention of the grant of the patent | 2010-06-09 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/GB2004/004502 |
Date | 2004-10-22 |
(87) | Number | WO 2005/042102 |
Date | 2005-05-12 |
(30) | Number | Date | Country code |
0324656 | 2003-10-22 | GB |
(72) |
BURGESS, Nicola Anne, Celltech R & D Limited, GB
|
(73) |
UCB Pharma, S.A.,
Allée de La Recherche 60, 1070 Brussels,
BE
|
(54) | A PROTEIN INVOLVED IN OVARIAN CANCER |
A PROTEIN INVOLVED IN OVARIAN CANCER |